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Background: Apis mellifera stings are a problem for public health worldwide, particularly in Latin America due to
the aggressiveness of its Africanized honeybees. Massive poisoning by A. mellifera venom (AmV) affects mainly the
cardiovascular system, and several works have described its actions on heart muscle. Nevertheless, no work on the
pharmacological action mechanisms of the AmV in isolated aorta has been reported. Thus, the present work aimed
to investigate the actions of AmV and its main fractions, phospholipase A2 (PLA2) and melittin, on isolated aorta
rings and a probable action mechanism.
Results: AmV and the complex PLA2 + melittin (0.1-50 μg/mL) caused contraction in endothelium-containing aorta
rings, but neither isolated PLA2 nor melittin were able to reproduce the effect. Endothelium removal did not
change the maximum vasoconstrictor effect elicited by AmV. Ca2+-free medium, as well as treatment with
phentolamine (5 μM), verapamil (10 μM), losartan (100 μM), and U-73122 (10 μM, a phospholipase C inhibitor),
eliminated the AmV-induced contractile effects.
Conclusions: In conclusion, AmV caused contractile effect in aorta rings probably through the involvement of
voltage-operated calcium channels, AT1 and α-adrenergic receptors via the downstream activation of
phospholipase C. The protein complex, PLA2 + melittin, was also able to induce vasoconstriction, whereas the
isolated proteins were not.
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Africanized honeybees are a poly-hybrid species found
in South America, mainly in Brazil, known for their
aggressiveness and involvement in mass attacks [1,2].
The clinical manifestations of bee envenomation are
characterized by local and systemic toxicity. Among
the systemic manifestations observed after bee stings
are cardiovascular changes and renal damage. Despite
the significant advances made in understanding the
pathogenesis of nephrotoxic and ischemic acute renal
failure caused by such envenomation, there have been
few changes in terms of mortality [3].
A. mellifera venom (AmV) is a complex mixture of
enzymes, peptides and amines. Among the components
of the venom are biogenic amines, hyaluronidases,* Correspondence: mhtjpn@yahoo.com
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reproduction in any medium, provided the orphospholipases A2 (PLA2) and melittin, which is its main
constituent, approximately 50% of the dry weight [4,5].
This active 26-amino-acid peptide is released from its
precursor, promelittin, during biosynthesis and presents
hemolytic activity. It also is the primary allergen found
in bee venom [6]. It acts synergistically with phospholipase
A2 (PLA2) to enhance its toxic actions [7].
Despite published in vivo characterization of the cardio-
vascular effects of both melittin and PLA2, few in vitro ex-
periments that clarify the action mode of these toxins are
available in the scientific literature [8]. Some papers report
the role of endothelium, lipoxygenase products, and nitric
oxide (NO) in the vascular effects of melittin [9-11]. The
present study aimed to investigate the vasoconstrictor effect
of crude A. mellifera venom (AmV) and its fractions PLA2,
melittin, and the native linked fraction (PLA2 + melittin),
on isolated aortic rings of rats.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Venom and reagents
A. mellifera venom was purchased from Bio-Agents
Serpentarium (Brazil). All chemicals and solvents were
of analytical grade and purchased from certified suppliers
(Bayer, Sigma-Aldrich, Labtest Diagnostic and Applied
Biosystems).
Animals
Male Wistar rats (250–300 g) were maintained under
standard conditions of temperature and humidity in
12-hour light–dark cycles. The animals had fasted for
24 hours before any experimental procedure, and water
was provided ad libitum. All experiments were in accord-
ance with the guidelines for the ethical use of experimental
animals published by the Brazilian College on Experimental
Animal Care (COBEA), with a project license approved
by the Animal Ethics Committee of Federal University
of Ceará (protocol number 01/2012).
Purification of PLA2 and melittin from Apis mellifera venom
The bee venom PLA2 was purified in two chromato-
graphic steps. Briefly, AmV was dissolved (10 mg/mL) in
NaCl 0.9% and kept at 14°C under constant stirring. The
protein content of the venom was precipitated with pure
acetone for 24 hours, centrifuged (4500 x g) and lyophilized
to obtain the protein fraction, which was used for the frac-
tionation of PLA2. In the first step, the protein fraction was
subjected to a molecular exclusion chromatography, using
a size exclusion column (1 x 60 cm) previously packed
with Superdex®75 (GE Healthcare Life Sciences, USA).
The column was attached to semi-preparative HPLC and
equilibrated with a 0.2M ammonium bicarbonate buffer
(pH 7.8). The protein fraction (15 mg) was dissolved in
250 μL of the buffer, homogenized, and centrifuged at
4500 x g for five minutes. The supernatant was filtered
through a 0.45 μm filter and then injected into the column.
Fractionation of the venom was performed at a constant
flow rate of 0.3 mL/minute and monitored at 280 nm. Each
fraction was collected for three minutes (0.9 mL) and tested
for phospholipase A2 enzymatic activity.
After confirming the PLA2 enzymatic activity, the
fraction was subjected to a new chromatographic step on
reversed-phase HPLC using a C18 semi-analytical column,
which was equilibrated with buffer A (0.1% TFA), to isolate
the PLA2 and melittin. Samples of the fraction with PLA2
activity (3 mg) were dissolved in 250 mL of buffer A, clari-
fied and injected into the chromatographic column. The
elution was performed with a continuous linear gradient of
buffer B (66% acetonitrile in 0.1% TFA) and the monitoring
was done at 280nm. The samples from the first chromato-
graphic step were analyzed by SDS-PAGE, using a running
gel of 12% acrylamide and a stacking gel of 5% acrylamide,
with bisacrylamide (0.32%) as cross-linker.Mass spectrometry
The molecular masses of the PLA2 and melittin were de-
termined by matrix-assisted laser desorption/ionization
time-of-flight (MALDI-TOF) mass spectrometry using
a Voyager-DE PROMALDI-TOF mass spectrometer
(Applied Biosystems®, Life Technologies™, USA). One
microliter of the sample dissolved in 0.1% TFA was mixed
with 2 μL of the matrix (α-cyano-4-hydroxycinnamic acid).
The matrix was prepared with 30% acetonitrile and 0.1%
TFA (v/v). Ion masses were determined at an acceleration
voltage of 25 kV, the laser operating at 2890 μJ/com2, with
a 300 ns delay and a linear analysis mode.
Aortic ring assay
The rats were sacrificed by stunning followed by cervical
dislocation. The thoracic aorta were removed and immersed
in a perfusion medium (Krebs-Henseleit solution) at room
temperature. After removing adhering fat and connective
tissue, each aorta was cut transversally into cylindrical
ring-like segments (1 x 5 mm) attached to steel wire
triangular pieces (0.3 mm diameter), which were suspended
in a 5 mL organ bath containing Krebs-Henseleit solution
(pH 7.4) with the following composition (mM): NaCl 118.0,
KCl 4.7, MgSO4 1.2, CaCl2 2.5, KH2PO4 1.2, NaHCO3
25.0 and glucose 11.1, continuously aerated at 37°C with
95% O2 and 5% CO2.
In some aortic tissues, endothelium was removed im-
mediately after dissection by gentle rubbing of the aortic
lumen with a stainless steel wire. Endothelium-containing
or denuded strips were stretched with a passive tension of
1 g while the tension was recorded using an isometric force
transducer (ML870B60/C-V, AD Instruments, Australia)
connected to a digital data acquisition system (PowerLab™
8/30, AD Instruments). After an equilibration period of at
least 60 minutes, control contractions were induced by
adding a submaximal concentration (60 mM) of potassium
chloride (KCl) to the bath. When two successive control
contractions showed similar amplitudes, preparations were
considered equilibrated. Contraction data were expressed
as percentages of the potassium-induced contraction.
Endothelium-containing or -denuded preparations were
contracted at the beginning of the experiment with potas-
sium (30 mM) and after establishment of a contractile
plateau, they were challenged with 1 μM of acetylcholine.
The lack of acetylcholine-induced vasorelaxant effects was
interpreted as evidence that the preparation was effectively
denuded of endothelium [3].
Effects of the A. mellifera venom (AmV) in isolated rat aorta
Concentration-effect curves of AmV were obtained by
exposing a preparation in basal tonus to cumulatively
increasing concentrations of AmV (0.1 to 50 μg/mL) added
to the bath and maintaining it at a given concentration
for five minutes. The vasoconstrictor effects of AmV were
Figure 1 Fractionation of AmV. (A) Chromatography of
whole protein extract from honeybee venom using a
molecular exclusion column packed with Superdex®75. The
chromatographic run was carried out at a flow rate of 0.6
mL/h and monitored at 280 nm. (B) Reverse phase HPLC run
yielded five main fractions designated from VI-1 to VI-5.
Fraction VI-3 was confirmed as PLA2 by specific phospholipase
A2 assay and fraction VI-4 as melittin after MALDI-TOFF
analysis. (C) SDS-PAGE analysis of the purified proteins.
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In order to investigate the vasoconstrictor effect of
AmV, concentration-effect curves were constructed by
exposing the preparations to cumulatively increasing
concentrations of AmV in basal tonus in preparations
maintained in a Ca2+-containing medium, in a Ca2+-free
medium (containing 2 x 10-5 M EGTA), and in the pres-
ence of verapamil (10 μM), a well-known L-type voltage-
operated Ca2+ channel (VOCC) blocker, phentolamine
(5 μM), an α-adrenergic blocker, losartan (100 μM), an
angiotensin II AT1 receptor antagonist, and U73122
(10 μM), a phospholipase C inhibitor.
Effects of the AmV fractions, PLA2 and melittin,
on isolated rat aorta
In order to investigate whether the fractions PLA2 and
melittin were involved in the vasoconstrictor effects of the
AmV, concentration-effect curves (0.1 to 50 μg/mL) were
constructed by exposing the preparations to cumulatively
increasing concentrations of the fractions, PLA2, melittin
and the complex PLA2 + melittin (1:1, w:w).
Statistical analysis
Data were reported as means ± SEM. The means were
evaluated by ANOVA, followed by the Holm-Sidak post
hoc test. Emax values were compared using the unpaired
Student’s t test. The acceptance level for statistically
significant differences was set at 5% (p < 0.05).
Results
Fractionation of A. mellifera crude venom
A. mellifera crude venom fractionation through size
exclusion chromatography showed the presence of nine
fractions, designated sequentially I to IX, as shown in
Figure 1A. Only the fraction VI showed phospholipasic
A2 enzymatic activity. The SDS-PAGE analysis of fraction
VI revealed the presence of two major fractions as well as a
minor electrophoretic band (results not shown). This
fraction was subjected to a reverse phase HPLC. The
chromatographic profile of the purification of the fraction
VI showed five peaks, which were denominated se-
quentially VI-1 to VI-5, where the most important
fractions in terms of chromatogram area were VI-3 and
VI-4 (Figure 1B). The analysis on SDS-PAGE of these
fractions showed that VI-3 had a molecular mass of
approximately 15 kDa (Figure 1C). Fraction VI-4 was not
detected using a 10% acrylamide gel. This result suggested
that fraction VI-4 must have a molecular mass lower than
10 kDa. PLA2 enzymatic activity was found only in fraction
VI-3, whereas fraction VI-4 reduced the PLA2 of fraction
VI-3. Finally, a MALDI-TOF analysis, to confirm the
molecular homogeneity of PLA2 and melittin, revealed
respective molecular masses of 15,343.31 Da and 3,101.03
Da for the PLA2 and melittin.Effect of A. mellifera venom and its fractions in isolated aorta
In endothelium-containing aorta preparations, AmV
(0.1-50 μg/mL) induced contractile responses in a
concentration-dependent manner. The magnitude of the
contraction induced by 50 μg/mL of AmV corresponded
to 92.6 ± 5.5% (n = 5 rings) of a reference contraction
induced by 60 mM K+. In the same preparation, the
isolated PLA2 or melittin (0.1-50 μg/mL) did not induce
significant contractile responses. However, the complex
PLA2 + melittin (0.1-50 μg/mL) induced a vasoconstrictor
effect in a concentration-dependent manner, (n = 4 rings;
p < 0.05; Figure 2A). The magnitude of the contractile
effect at 50 μg/mL was 66.1 ± 11.9% of the contraction
induced by K+ (60 mM). Endothelium removal did not
change the maximum vasoconstrictor effect elicited by
AmV (Figure 2B).
Figure 2 Characterization of the vasoconstrictor effect of AmV.
(A) Vasoconstrictor effect of AmV (0.1-50 μg/mL) (●, n = 5) and the
fractions: melittin (■, n = 5); PLA2 (Ο, n = 5); and the complex
PLA2 + melittin (□, n = 5). (B) Effect of endothelium removal on
AmV vasoconstrictor effect. The concentration response curve of
AmV (0.1-50 μg/mL) on basal tone in endothelium-containing aorta
preparations (●, n = 5), and in endothelium-denuded aorta
preparations (Ο, n = 4). Vasoconstrictor effects are expressed as a
percentage of the contractile response to K+ (60 mM). Data are
expressed as mean ± SEM and analyzed by ANOVA followed by the
Holm-Sidak post hoc test.
Figure 3 Study on the probable action mode of AmV.
Vasoconstrictor effects of AmV: (A) Ca2+-free medium (Ο, n = 5);
(B) pretreatment with phentolamine (5 μM; □, n = 5); (C)
pretreatment with verapamil (10 μM; Δ, n = 5). Vasoconstrictor
effects are expressed as a percentage of the contractile response
to K+ (60 mM). Data are expressed as mean ± SEM and analyzed
by ANOVA followed by the Holm-Sidak posttest.
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isolated aorta
In aortic rings maintained in the Ca2+-free medium, the
contractile effects induced by AmV were abolished and
the magnitude of the maximal contraction was 3.7 ± 3.0%
of the K+ (60 mM) value (n = 5; p < 0.05; Figure 3A),
a value significantly lower than that observed in
Ca2+-containing medium. Pretreatment of aortic rings
with phentolamine (5 μM) also significantly reduced
AmV -induced contraction (50 μg/mL) to 26.8 ± 5.6% of
the K+ (60 mM) value (n = 5 rings; p < 0.05; Figure 3B).
In order to evaluate the effect of a voltage-gated calcium
channel blocker on AmV-induced contraction, prepara-
tions were treated with verapamil (10 μM) after which thecontractions elicited by AmV (50 μg/mL) significantly
diminished to 21.7 ± 3.3% of the K+ (60 mM) value (n = 4
rings; p < 0.05; Figure 3C).
Aiming to verify whether angiotensin was involved in the
contractions induced by AmV, an AT1 receptor antagonist
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(100 μM), and the contractions elicited by AmV were
decreased to 27.3 ± 2.4% of the K+ (60 mM) value (n = 4
rings; p < 0.05; Figure 4A). Moreover, pretreatment of
aortic rings with U-73122 (10 μM), a phospholipase C
inhibitor, significantly reduced AmV-induced contraction
(50 μg/mL) to 38.4 ± 5.6% of the K+ (60mM) value, re-
spectively (n = 5 rings; p < 0.05; Figure 4B).
Discussion
The present work describes the isolation of three fractions
from the venom of A. mellifera, a mixed fraction of PLA2
and melittin, and both in pure protein form PLA2 and
melittin. These proteins together represent approximately
60% of the venom dry weight [12,13]. A vasoconstrictor
effect of AmV and the complex PLA2 + melittin was
confirmed. However, the isolated PLA2 and melittin had
no contractile effect on the aortic rings. Some authors
reported that melittin facilitates the interaction of PLA2Figure 4 Study on the probable action mode of AmV.
Vasoconstrictor effects of AmV: (A) pretreatment with losartan
(100 μM; Ο, n = 5); (B) pretreatment with U-73122 (10 μM; □, n = 5).
Vasoconstrictor effects are expressed as a percentage of the contractile
response to K+ (60 mM). Data are expressed as mean ± SEM and
analyzed by ANOVA followed by the Holm-Sidak posttest.with the cell membrane, exposing the membrane to the
catalytic site of the enzyme due to its amphipathic
characteristics [3]. In order to investigate the action
mode of A. mellifera-induced vasoconstriction, the involve-
ments of extracellular Ca2+, voltage-gated calcium channels,
α2-adrenergic receptors, AT1 receptors and phospholipase
C were assayed.
In Ca2+-free medium, an inhibition of the contractile
response of AmV was observed. Likewise, employing
verapamil, a calcium channel blocker, produced an absence
of the AmV-induced contractile response. We suggested
that the vasoconstrictor properties are dependent on a
trans-membrane Ca2+ influx. Thus, the opening of voltage-
operated calcium channels is involved in the mechanism
proposed for the contractile effect of AmV.
In most cases, a smooth muscle contraction involves a
combination of input and Ca2+ release. The various types
of smooth muscle may differ markedly in this regard:
in the relative contribution of the two sources of Ca2+
for contraction (intracellular and extracellular) and in ion
channels through which extracellular Ca2+ can have access
to the interior of the cell [14]. According to Jackson
[15], the contraction of vascular smooth muscle occurs
primarily by the influx of Ca2+ into the muscle cell. If
the extracellular concentration of Ca2+ is reduced, the
contraction is almost eliminated.
Adrenergic receptors consist of typical G-protein-coupled
receptors. Each of these receptor classes, α1- and α2-
adrenergic receptors, is associated with a specific system
of secondary messengers. The α1-adrenergic receptors
are coupled to phospholipase C and produce their effects
mainly through the release of intracellular Ca2+ stores,
mediating vasoconstriction [16].
In an attempt to elucidate the pathway involved in the
contraction of the aorta by AmV, an α-adrenergic recep-
tor blocker (phentolamine), an AT1 receptor antagonist
(losartan), and a phospholipase C inhibitor (U-73122) were
used. A significant reduction in the contractile effect
of AmV on the aortic rings was observed, suggesting
the involvement of these receptors in tissue contraction
via phospholipase C.
This hypothesis is corroborated by Vinhote et al. [17],
who reported such contraction in aortic rings, induced
by Polybia paulista wasp venom, showing that the effect
was dependent on voltage-operated calcium channels, and
that α-adrenergic receptors were involved.
Conclusions
In conclusion, Apis mellifera venom causes a contractile
effect on aorta rings probably through the involvement of
voltage-operated calcium channels, AT1 and α-adrenergic
receptors via the downstream activation of phospholipase
C. In contrast to the isolated proteins, the protein complex
PLA2 + melittin was also able to induce vasoconstriction.
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